Issue |
Title |
File |
Vol 51, No 6 (2017) |
Targeted Bifunctional Proteins and Hybrid Nanoconstructs for Cancer Diagnostics and Therapies |
 (Eng)
|
Deyev S.M., Lebedenko E.N.
|
Vol 51, No 6 (2017) |
In vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus |
 (Eng)
|
Argentova V.V., Aliev T.K., Zarubaev V.V., Klotchenko S.A., Shtro A.A., Sergeeva M.V., Toporova V.A., Dolgikh D.A., Sveshnikov P.G., Vasin V.A., Kirpichnikov M.P.
|
Vol 51, No 6 (2017) |
Analysis of the Specificity of IgA Antibodies Produced in the Mouse Small Intestine |
 (Eng)
|
Sharanova N.E., Ninnemann J., Bondareva M.A., Semin Y.K., Nomokonova A.V., Kruglov A.A.
|
Vol 51, No 6 (2017) |
Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination |
 (Eng)
|
Vzorov A.N., Uryvaev L.V.
|
Vol 51, No 6 (2017) |
Peculiarities of the Mechanism of Interactions of Catalytic Antibodies with Organophosphorus Substrates |
 (Eng)
|
Vorobiev I.I., Mokrushina Y.A., Pipiya S.O., Stepanova A.V., Shamborant O.G., Knorre V.D., Smirnov I.V., Gabibov A.G.
|
Vol 51, No 6 (2017) |
Exceptional Diversity of Catalytic Antibodies with Varying Activity in the Blood of Autoimmune and Viral Disease Patients |
 (Eng)
|
Buneva V.N., Nevinsky G.A.
|
Vol 51, No 6 (2017) |
A Method for the Parallel and Sequential Generation of Single-Domain Antibodies for the Proteomic Analysis of Human Blood Plasma |
 (Eng)
|
Goryainova O.S., Ivanova T.I., Rutovskaya M.V., Tillib S.V.
|
Vol 51, No 6 (2017) |
Bifunctional Toxin DARP-LoPE Based on the Her2-Specific Innovative Module of a Non-Immunoglobulin Scaffold as a Promising Agent for Theranostics |
 (Eng)
|
Proshkina G.M., Kiseleva D.V., Shilova O.N., Ryabova A.V., Shramova E.I., Stremovskiy O.A., Deyev S.M.
|
Vol 51, No 6 (2017) |
T Lymphocytes with Modified Specificity in the Therapy of Malignant Diseases |
 (Eng)
|
Vdovin A.S., Bykova N.A., Efimov G.A.
|
Vol 51, No 6 (2017) |
Recombinant Monoclonal Antibodies, from Tumor Targeting to Cancer Immunotherapy: A Critical Overview |
 (Eng)
|
Mach J.
|
Vol 51, No 6 (2017) |
Antibody Engineering: From the Idea to Its Implementation |
 (Eng)
|
Polanovsky O.L.
|
Vol 51, No 6 (2017) |
Conformational Fingerprinting Using Monoclonal Antibodies (on the Example of Angiotensin I-Converting Enzyme-ACE) |
 (Eng)
|
Danilov S.M.
|
Vol 51, No 6 (2017) |
Humanization of Murine Monoclonal anti-hTNF Antibody: The F10 Story |
 (Eng)
|
Efimov G.A., Raats J.M., Chirivi R.G., van Rosmalen J.W., Nedospasov S.A.
|
Vol 51, No 6 (2017) |
Antibody-Based Drugs and Other Recombinant Proteins for Diagnostics and Therapy of Viral Infections, Autoimmune Diseases and Cancer |
 (Eng)
|
Kuprash D.V., Garib F.Y., Nedospasov S.A.
|
Vol 51, No 6 (2017) |
Engineering Antibodies as Drugs: Principles and Practice |
 (Eng)
|
Lugovskoy A.A.
|
Vol 51, No 6 (2017) |
Next-Generation Techniques for Discovering Human Monoclonal Antibodies |
 (Eng)
|
Lushova A.A., Biazrova M.G., Prilipov A.G., Sadykova G.K., Kopylov T.A., Filatov A.V.
|
1 - 16 of 16 Items |
|